Timm Baumeister

Forma Therapeutics (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

9h-index377citations12works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Biochemical and Molecular Research(9), Sirtuins and Resveratrol in Medicine(8), Autophagy in Disease and Therapy(4), PARP inhibition in cancer therapy(3), Cancer Genomics and Diagnostics(2)

Publications12 total

Discovery of novel biaryl sulfonamide based Mcl-1 inhibitors
Bioorganic & Medicinal Chemistry Letters·2019· 8 cited
Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Journal of Visualized Experiments·2015Open Access
Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Journal of Visualized Experiments·2015· 2 cited
Identification of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with no evidence of CYP3A4 time-dependent inhibition and improved aqueous solubility
Bioorganic & Medicinal Chemistry Letters·2014· 28 citedOpen Access
Fragment-Based Identification of Amides Derived from <i>trans</i>-2-(Pyridin-3-yl)cyclopropanecarboxylic Acid as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)
Journal of Medicinal Chemistry·2014· 38 citedOpen Access
Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)
Bioorganic & Medicinal Chemistry Letters·2013· 23 citedOpen Access
Discovery of potent and efficacious cyanoguanidine-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitors
Bioorganic & Medicinal Chemistry Letters·2013· 16 citedOpen Access
Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)
Bioorganic & Medicinal Chemistry Letters·2013· 41 citedOpen Access
Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors
Journal of Medicinal Chemistry·2013· 80 citedOpen Access
Identification of 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived ureas as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)
Bioorganic & Medicinal Chemistry Letters·2013· 32 citedOpen Access
Structure-Based Identification of Ureas as Novel Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors
Journal of Medicinal Chemistry·2013· 68 citedOpen Access
Discovery of potent and efficacious urea-containing nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with reduced CYP2C9 inhibition properties
Bioorganic & Medicinal Chemistry Letters·2013· 41 citedOpen Access

Frequent Co-authors

Xiaozhang Zheng(10), Yen‐Ching Ho(9), Peter S. Dragovich(9), Weiru Wang(9), Mark Zak(9), Po‐wai Yuen(9), Kenneth W. Bair(9), Zhongguo Wang(7), Thomas O’Brien(7), Yang Xiao(7), Alexandre J. Buckmelter(6), Karl H. Clodfelter(6), Bingsong Han(6), Jian Lin(6), Dominic J. Reynolds(6), Chase C. Smith(6), Bianca M. Liederer(6), Angela Oh(6), Gui‐Ling Zhao(6), Nicholas J. Skelton(6)